Stephen B. Baylin, MD
The Johns Hopkins University School of Medicine
Dr. Baylin has spent his career working on mechanisms through which cell populations evolve during the formation or production of tumors. Over the past 20 years, his work has concentrated on aberrant epigenetic gene silencing, which plays a major role in cancer formation by inactivating tumor suppressor genes. Dr. Baylin and his team have helped outline the genes involved in epigenetic silencing and are identifying new markers for cancer risk assessment, prevention, diagnosis, and treatment.
Epigenetics and Its Place on the Road to Cancer
Stephen B. Baylin, MD, and Cancer Center Director Michelle Le Beau, PhD